State Of Wyoming Viracta Therapeutics, Inc. Transaction History

State Of Wyoming

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$2.23 - $4.76 $1,335 - $2,851	-599 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$3.37 - $7.91 $16 - $39	-5 Reduced 0.83%	599 $2,000
Q3 2021 Feb 11, 2022	BUY	$7.84 - $12.53 $4,037 - $6,452	515 Added 578.65%	604 $5,000
Q2 2021 Feb 11, 2022	BUY	$7.55 - $12.95 $671 - $1,152	89 New	89 $1,000

9.03M

10.9K

400

Ticker VIRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,558,200
Market Cap $8.64M
Description
Viracta Therapeutics, Inc., a precision oncology company, engages in developing drugs for the treatment of virus-associated malignancies. Its lead product candidature includes Nana-val, in combination with nanatinostat and valganciclovir that is in Phase II clinical trial for Epstein-Barr virus-positive lymphoma; and open-label Phase 2 basket tr...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.